Should I buy or sell Baxter International stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares. View BAX analyst ratings or view top-rated stocks .

What is Baxter International's stock price target for 2024?

9 Wall Street analysts have issued 12-month target prices for Baxter International's shares. Their BAX share price targets range from $36.00 to $56.00. On average, they expect the company's stock price to reach $46.30 in the next year. This suggests a possible upside of 15.6% from the stock's current price. View analysts price targets for BAX or view top-rated stocks among Wall Street analysts .

How have BAX shares performed in 2024?

Baxter International's stock was trading at $38.66 at the start of the year. Since then, BAX shares have increased by 3.6% and is now trading at $40.04. View the best growth stocks for 2024 here .

Are investors shorting Baxter International?

Baxter International saw a decrease in short interest in March. As of March 31st, there was short interest totaling 7,620,000 shares, a decrease of 6.8% from the March 15th total of 8,180,000 shares. Based on an average trading volume of 3,700,000 shares, the short-interest ratio is presently 2.1 days. View Baxter International's Short Interest .

When is Baxter International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our BAX earnings forecast .

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link .

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) released its quarterly earnings data on Thursday, February, 8th. The medical instruments supplier reported $0.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.02. The medical instruments supplier earned $3.89 billion during the quarter, compared to analysts' expectations of $3.81 billion. Baxter International had a trailing twelve-month return on equity of 19.49% and a net margin of 17.77%. The company's quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.88 EPS. Read the conference call transcript .

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Monday, February 12th. Stockholders of record on Friday, March 1st will be given a dividend of $0.29 per share on Monday, April 1st. This represents a $1.16 dividend on an annualized basis and a yield of 2.90%. The ex-dividend date of this dividend is Thursday, February 29th. Read our dividend analysis for BAX .

Is Baxter International a good dividend stock?

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.88%. The dividend payout ratio is 22.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BAX will have a dividend payout ratio of 36.25% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for BAX .

What ETFs hold Baxter International's stock?

ETFs with the largest weight of Baxter International (NYSE:BAX) stock in their portfolio include BTD Capital Fund (DIP) , First Trust Indxx Medical Devices ETF (MDEV) , iShares U.S. Medical Devices ETF (IHI) , BlackRock Large Cap Value ETF (BLCV) , Invesco Zacks Mid-Cap ETF (CZA) , Global X S&P 500 Quality Dividend ETF (QDIV) , Invesco S&P 500 Equal Weight Health Care ETF (RSPH) and SPDR S&P Health Care Equipment ETF (XHE) .

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its first quarter 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of 0.590-0.620 for the period, compared to the consensus earnings per share estimate of 0.620. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $3.6 billion.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com . José (Joe) Almeida has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include Xtrackers California Municipal Bond ETF (CA) , Johnson & Johnson (JNJ) , Pfizer (PFE) , Cisco Systems (CSCO) , Intel (INTC) , Abbott Laboratories (ABT) , Procter & Gamble (PG) , AT&T (T) and Verizon Communications (VZ) .

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pensioenfonds Rail & OV (0.17%), ARGA Investment Management LP (0.05%), Trust Co. of Toledo NA OH (0.00%), Neville Rodie & Shaw Inc. (0.00%), GAMMA Investing LLC (0.00%) and Kingswood Wealth Advisors LLC (0.00%). Insiders that own company stock include Albert P L Stroucken , Brian Stevens , Jacqueline Kunzler and Jeanne K Mason . View institutional ownership trends .

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc.. Read More

NYSE:BAX

Baxter International (BAX) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free BAX Stock Alerts

$40.04

-0.29 (-0.72%)

(As of 04/15/2024 ET)

Compare

Today's Range: $39.82
▼
$40.85
50-Day Range: $39.38
▼
$43.77
52-Week Range: $31.01
▼
$50.21

Volume: 3.01 million shs
Average Volume: 3.74 million shs
Market Capitalization: $20.33 billion

P/E Ratio: 7.67
Dividend Yield: 2.90%
Price Target: $46.30

Get Baxter International alerts:

Baxter International MarketRank™ Stock Analysis

Analyst Rating: Hold
2.22 Rating Score
Upside/Downside: 15.6% Upside
$46.30 Price Target
Short Interest: Healthy
1.50% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -1.95
Upright™ Environmental Score
News Sentiment: 0.44
Based on 9 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 10.73%
From $2.89 to $3.20 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.89 out of 5 stars

Medical Sector

29th out of 928 stocks

Surgical & Medical Instruments Industry

4th out of 99 stocks

3.1

Analyst's Opinion

Consensus Rating
Baxter International has received a consensus rating of Hold. The company's average rating score is 2.22, and is based on 2 buy ratings, 7 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Baxter International has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
1.50% of the outstanding shares of Baxter International have been sold short.
Short Interest Ratio / Days to Cover
Baxter International has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Baxter International has recently decreased by 6.85%, indicating that investor sentiment is improving significantly.

2.5

Dividend Strength

Dividend Yield
Baxter International pays a meaningful dividend of 2.88%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Baxter International does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Baxter International is 22.22%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Baxter International will have a dividend payout ratio of 36.25% next year. This indicates that Baxter International will be able to sustain or increase its dividend.

4.0

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Baxter International has received a 55.71% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Vaccines (J07)", "Blood plasma proteins", and "Anaesthetics (N01)" products. See details.
Environmental Sustainability
The Environmental Impact score for Baxter International is -1.95.

2.5

News and Social Media Coverage

News Sentiment
Baxter International has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 9 news articles for Baxter International this week, compared to 8 articles on an average week.
Search Interest
Only 10 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.
MarketBeat Follows
11 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is an increase of 38% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Baxter International insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.22% of the stock of Baxter International is held by insiders.
Percentage Held by Institutions
90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Baxter International are expected to grow by 10.73% in the coming year, from $2.89 to $3.20 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Baxter International is 7.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.25.
Price to Earnings Ratio vs. Sector
The P/E ratio of Baxter International is 7.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 237.87.
Price to Earnings Growth Ratio
Baxter International has a PEG Ratio of 2.17. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Baxter International has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

>>Check out what this A.I. Perfect Storm is<<

About Baxter International Stock (NYSE:BAX)

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

BAX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BAX Stock News Headlines

April 15, 2024 | marketwatch.com

Exact Sciences Taps Aaron Bloomer as Finance Chief

April 13, 2024 | americanbankingnews.com

Baxter International Inc. (NYSE:BAX) Receives Average Recommendation of "Hold" from Brokerages

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

April 12, 2024 | finance.yahoo.com

Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day

April 11, 2024 | msn.com

Exeter Chiefs boss Rob Baxter casts doubts on financial viability of Club World Cup

April 11, 2024 | businesswire.com

Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.

April 10, 2024 | businesswire.com

Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors

April 10, 2024 | finance.yahoo.com

Baxter Is Deeply Undervalued

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

April 5, 2024 | finance.yahoo.com

Shareholders in Baxter International (NYSE:BAX) are in the red if they invested three years ago

April 4, 2024 | msn.com

Pfizer, Thermo Fisher Among 200 Companies Warned by FTC Over Deals

April 3, 2024 | markets.businessinsider.com

Assessing Baxter Intl: Insights From 4 Financial Analysts

April 2, 2024 | finance.yahoo.com

Musician Jeffrey "Skunk" Baxter to Receive the Hedy Lamarr Unsung Heroes in Science & Technology Award at EarthX Congress of Conferences

April 2, 2024 | msn.com

Skilled Workforce: International Brotherhood of Electrical Workers

April 2, 2024 | msn.com

Trudeau says temporary immigration needs to be brought ‘under control’

April 1, 2024 | yahoo.com

Warby Parker promotes free eclipse glasses with 'Poor Things' Bella Baxter lookalike

April 1, 2024 | msn.com

Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System

April 1, 2024 | finance.yahoo.com

Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy

March 31, 2024 | msn.com

Commentary: Gabriel Pec scores early as Galaxy defeats Seattle to continue its hot start

March 31, 2024 | msn.com

Young wrestler Keiva Sherlock takes international crown

March 29, 2024 | uk.sports.yahoo.com

The cavalry is coming: Evatt confirms comeback plan for Charles and Baxter

March 28, 2024 | msn.com

THE BAXTERS : STREAM IT OR SKIP IT?

March 28, 2024 | finance.yahoo.com

Baxter International Inc.: Obesity Drug's Effects on Dialysis Likely To Be Less Than Feared

March 28, 2024 | uk.sports.yahoo.com

TEAM NEWS: Evatt's curt words spark debate over Charles and Baxter's fitness

March 27, 2024 | yahoo.com

QCSO names new youth ensembles director

March 27, 2024 | msn.com

Emma Stone follows up Oscar win with wild teaser for her next movie from ‘Poor Things’ director Yorgos Lanthimos

March 27, 2024 | uk.sports.yahoo.com

Evatt: Charles and Baxter WON'T play against Stevenage on Good Friday

See More Headlines

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/08/2024
Ex-Dividend for 4/1 Dividend: 2/29/2024
Dividend Payable: 4/01/2024
Today: 4/15/2024
Next Earnings (Confirmed): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Current Symbol: NYSE:BAX
CUSIP: 07181310
CIK: 10456
Web: www.baxter.com
Phone: (224) 948-2000
Fax: 224-948-1813
Employees: 60,000
Year Founded: 1931

Price Target and Rating

Average Stock Price Target: $46.30
High Stock Price Target: $56.00
Low Stock Price Target: $36.00
Potential Upside/Downside: +15.6%
Consensus Rating: Hold
Rating Score (0-4): 2.22
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): $5.22
Trailing P/E Ratio: 7.67
Forward P/E Ratio: 13.85
P/E Growth: 2.17
Net Income: $2.66 billion
Net Margins: 17.77%
Pretax Margin: -0.70%
Return on Equity: 19.49%
Return on Assets: 4.77%

Debt

Debt-to-Equity Ratio: 1.31
Current Ratio: 1.48
Quick Ratio: 1.04

Sales & Book Value

Annual Sales: $14.81 billion
Price / Sales: 1.37
Cash Flow: $5.21 per share
Price / Cash Flow: 7.69
Book Value: $16.69 per share
Price / Book: 2.40

Miscellaneous

Outstanding Shares: 507,830,000
Free Float: 506,710,000
Market Cap: $20.33 billion
Optionable: Optionable
Beta: 0.62

Social Links

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Jose E. Almeida (Age 62)
Chairman of the Board, President & CEO
Comp: $3.62M
Mr. Joel T. Grade (Age 53)
Executive VP & CFO
Comp: $829.82k
Ms. Heather Knight (Age 52)
Executive VP & Group President of Medical Products and Therapies
Comp: $1.63M
Mr. Alok Sonig B.E. (Age 52)
Mba, Executive VP & Group President of Pharmaceuticals
Comp: $1.56M
Mr. Christopher A. Toth (Age 44)
Executive VP & Group President of Kidney Care
Comp: $5.26M
Mr. Talvis P. Love (Age 56)
Senior VP & Chief Information Officer
Ms. Tobi Karchmer M.D.
M.S., Senior VP and Chief Medical & Scientific Officer
Ms. Clare Trachtman
Vice President of Investor Relations
Mr. David S. Rosenbloom (Age 64)
Executive VP & General Counsel
Comp: $776.51k
Ms. Stacey Eisen
?Senior Vice President, Chief Communications Officer & Corporate Marketing?

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

Should I Buy Baxter International Stock? BAX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Baxter International Inc.:

Baxter International Inc. reported strong quarterly earnings, beating the consensus estimate, which indicates financial stability and growth potential.
The company has a diverse portfolio of healthcare products, including advanced surgical equipment, patient monitoring technologies, and respiratory health devices, catering to various healthcare needs.
Baxter International Inc. has a solid return on equity of 19.49%, showcasing efficient utilization of shareholder funds to generate profits.
The stock price of Baxter International Inc. has been relatively stable, with a market cap of $21.64 billion, indicating a well-established position in the market.
The company operates in approximately 100 countries, providing a global presence and access to diverse markets for potential growth opportunities.

Cons

Investors should be bearish about investing in Baxter International Inc. for these reasons:

The company's stock has a beta of 0.62, indicating lower volatility compared to the market, which may result in slower price movements for traders seeking quick gains.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

BAX Stock Analysis - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings or view top-rated stocks.
What is Baxter International's stock price target for 2024?: 9 Wall Street analysts have issued 12-month target prices for Baxter International's shares. Their BAX share price targets range from $36.00 to $56.00. On average, they expect the company's stock price to reach $46.30 in the next year. This suggests a possible upside of 15.6% from the stock's current price.
View analysts price targets for BAX or view top-rated stocks among Wall Street analysts.
How have BAX shares performed in 2024?: Baxter International's stock was trading at $38.66 at the start of the year. Since then, BAX shares have increased by 3.6% and is now trading at $40.04.
View the best growth stocks for 2024 here.
Are investors shorting Baxter International?: Baxter International saw a decrease in short interest in March. As of March 31st, there was short interest totaling 7,620,000 shares, a decrease of 6.8% from the March 15th total of 8,180,000 shares. Based on an average trading volume of 3,700,000 shares, the short-interest ratio is presently 2.1 days.
View Baxter International's Short Interest.
When is Baxter International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our BAX earnings forecast.
How can I listen to Baxter International's earnings call?: Baxter International will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Baxter International's earnings last quarter?: Baxter International Inc. (NYSE:BAX) released its quarterly earnings data on Thursday, February, 8th. The medical instruments supplier reported $0.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.02. The medical instruments supplier earned $3.89 billion during the quarter, compared to analysts' expectations of $3.81 billion. Baxter International had a trailing twelve-month return on equity of 19.49% and a net margin of 17.77%. The company's quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.88 EPS.
Read the conference call transcript.
How often does Baxter International pay dividends? What is the dividend yield for Baxter International?: Baxter International declared a quarterly dividend on Monday, February 12th. Stockholders of record on Friday, March 1st will be given a dividend of $0.29 per share on Monday, April 1st. This represents a $1.16 dividend on an annualized basis and a yield of 2.90%. The ex-dividend date of this dividend is Thursday, February 29th.
Read our dividend analysis for BAX.

Is Baxter International a good dividend stock?: Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.88%. The dividend payout ratio is 22.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BAX will have a dividend payout ratio of 36.25% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BAX.
What ETFs hold Baxter International's stock?: ETFs with the largest weight of Baxter International (NYSE:BAX) stock in their portfolio include BTD Capital Fund (DIP), First Trust Indxx Medical Devices ETF (MDEV), iShares U.S. Medical Devices ETF (IHI), BlackRock Large Cap Value ETF (BLCV), Invesco Zacks Mid-Cap ETF (CZA), Global X S&P 500 Quality Dividend ETF (QDIV), Invesco S&P 500 Equal Weight Health Care ETF (RSPH) and SPDR S&P Health Care Equipment ETF (XHE).
What guidance has Baxter International issued on next quarter's earnings?: Baxter International issued an update on its first quarter 2024 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of 0.590-0.620 for the period, compared to the consensus earnings per share estimate of 0.620. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $3.6 billion.
What is José (Joe) Almeida's approval rating as Baxter International's CEO?: 506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.
What other stocks do shareholders of Baxter International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include Xtrackers California Municipal Bond ETF (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).
Who are Baxter International's major shareholders?: Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pensioenfonds Rail & OV (0.17%), ARGA Investment Management LP (0.05%), Trust Co. of Toledo NA OH (0.00%), Neville Rodie & Shaw Inc. (0.00%), GAMMA Investing LLC (0.00%) and Kingswood Wealth Advisors LLC (0.00%). Insiders that own company stock include Albert P L Stroucken, Brian Stevens, Jacqueline Kunzler and Jeanne K Mason.
View institutional ownership trends.
How do I buy shares of Baxter International?: Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Baxter International have any subsidiaries?: The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More

This page (NYSE:BAX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Baxter International (BAX) Stock Price, News & Analysis

Baxter International MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Baxter International Stock (NYSE:BAX)

BAX Stock Price History

BAX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

Should I Buy Baxter International Stock? BAX Pros and Cons Explained

Pros

Cons

BAX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™